Symptom variability over the course of the day in patients with stable COPD in Brazil: a real-world observational study

被引:4
|
作者
Cukier, Alberto [1 ]
de Godoy, Irma [2 ]
da Costa, Claudia Henrique [3 ]
Rubin, Adalberto Sperb [4 ]
Gregorio, Marcelo Gervilla [5 ]
de Albuquerque Neto, Aldo Agra [6 ]
Lima, Marina Andrade [7 ]
Pereira, Monica Corso [8 ]
Tanni, Suzana Erico [2 ]
Athanazio, Rodrigo Abensur [1 ]
Cardoso Bessa, Elizabeth Jauhar [3 ]
Wehrmeister, Fernando Cesar [9 ]
Lourenco, Cristina Bassi [10 ]
Baptista Menezes, Ana Maria [9 ]
机构
[1] Univ Sao Paulo, Div Pneumol, Inst Coracao, InCor,Hosp Clin,Fac Med, Sao Paulo, SP, Brazil
[2] Univ Estadual Paulista UNESP, Disciplina Pneumol, Fac Med Botucatu, Botucatu, SP, Brazil
[3] Univ Estado Rio de Janeiro UERJ, Disciplina Pneumol, Rio De Janeiro, RJ, Brazil
[4] Univ Fed Ciencias Saude Porto Alegre, Santa Casa Misericordia Porto Alegre, Porto Alegre, RS, Brazil
[5] Clin Med Netspiro, Sao Bernardo Do Campo, SP, Brazil
[6] Univ Fed Sao Paulo UNIFESP, Ctr Reabilitacao Pulm, Dept Pneumol, Sao Paulo, SP, Brazil
[7] Hosp Dia Pulmao, Blumenau, SC, Brazil
[8] Univ Estadual Campinas, Fac Ciencias Med, Dept Clin Med, Disciplina Pneumol, Campinas, SP, Brazil
[9] Univ Fed Pelotas, Programa Posgrad Epidemiol, Pelotas, RS, Brazil
[10] AstraZeneca Brasil, Sao Paulo, SP, Brazil
关键词
Pulmonary disease; chronic obstructive; Signs and symptoms; respiratory; Quality of life; Disease progression; Brazil; OBSTRUCTIVE PULMONARY-DISEASE; EARLY-MORNING SYMPTOMS; RESPIRATORY SYMPTOMS; PHYSICAL-ACTIVITY; PSYCHOMETRIC PROPERTIES; IMPACT; PREVALENCE; PERCEPTION; NIGHTTIME; RISK;
D O I
10.36416/1806-3756/e20190223
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Objective: To analyze symptoms at different times of day in patients with COPD. Methods: This was a multicenter, cross-sectional observational study conducted at eight centers in Brazil. We evaluated morning, daytime, and nighttime symptoms in patients with stable COPD. Results: We included 593 patients under regular treatment, of whom 309 (52.1%) were male and 92 (15.5%) were active smokers. The mean age was 67.7 years, and the mean FEV1 was 49.4% of the predicted value. In comparison with the patients who had mild or moderate symptoms, the 183 (30.8%) with severe symptoms were less physically active (p = 0.002), had greater airflow limitation (p < 0.001), had more outpatient exacerbations (p = 0.002) and more inpatient exacerbations (p = 0.043), as well as scoring worse on specific instruments. The most common morning and nighttime symptoms were dyspnea (in 45.2% and 33.1%, respectively), cough (in 37.5% and 33.3%, respectively), and wheezing (in 24.4% and 27.0%, respectively). The intensity of daytime symptoms correlated strongly with that of morning symptoms (r = 0.65, p < 0.001) and that of nighttime symptoms (r = 0.60, p < 0.001), as well as with the COPD Assessment Test score (r = 0.62; p < 0.001), although it showed only a weak correlation with FEV 1 (r = -0.205; p < 0.001). Conclusions: Dyspnea was more common in the morning than at night. Having morning or nighttime symptoms was associated with greater daytime symptom severity. Symptom intensity was strongly associated with poor quality of life and with the frequency of exacerbations, although it was weakly associated with airflow limitation.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Daily symptom variability in patients with stable COPD in Brazil
    Penha, Marcio
    Baptista Menezes, Ana Maria
    Godoy, Irma
    Costa, Claudia Henrique
    Rubin, Adalberto
    Gregorio, Marcelo
    Lima, Marina
    Albuquerque Neto, Aldo
    Pereira, Monica Corso
    Tanni, Suzana
    Athanazio, Rodrigo
    Bessa, Elizabeth
    Wehrmeister, Fernando
    Lourenco, Cristina
    Cukier, Alberto
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [2] STABLE CLINICAL COURSE OF COPD PATIENTS IN THE ERA OF DUAL BRONCHODILATOR THERAPY: THE REAL-WORLD DATA
    Shin, Sun Hye
    Kang, Noeul
    Cho, Juhee
    Park, Hye Yun
    RESPIROLOGY, 2019, 24 : 173 - 173
  • [3] Real-world medication use patterns in stable COPD patients from Romania
    Mihaltan, Florin
    Postolache, Paraschiva
    Arghir, Oana Cristina
    Fira-Mladinescu, Ovidiu
    Silviu, Alecu
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [4] Real-world exacerbation rates in Japanese patients with COPD: results from the EXACOS observational cohort study
    Ding, Bo
    Zaha, Rebecca
    Ishida, Masato
    Graham, Sophie
    Hayashi, Ai
    Huse, Sam
    Mullerova, Hana
    Muro, Shigeo
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [5] How Stable Is Stable in COPD? An Analysis of Day-to-Day EXACT Score Variability in Acute and Stable Patients with COPD
    Leidy, N. K.
    Wilcox, T. K.
    Sethi, S.
    Jones, P. W.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [6] Daily Symptom Variability in Patients With Stable COPD: A Narrative Review
    Wu, Maochun
    Wang, Zequan
    Li, Manman
    Li, Kun
    WESTERN JOURNAL OF NURSING RESEARCH, 2018, 40 (10) : 1543 - 1561
  • [7] Efficacy of mepolizumab in elderly patients with severe asthma and overlapping COPD in real-world settings: A retrospective observational study
    Isoyama, Shoko
    Ishikawa, Nobuhisa
    Hamai, Kosuke
    Matsumura, Mirai
    Kobayashi, Hiroki
    Nomura, Akio
    Ueno, Sayaka
    Tanimoto, Takuya
    Maeda, Hiroyuki
    Iwamoto, Hiroshi
    Hattori, Noboru
    RESPIRATORY INVESTIGATION, 2021, 59 (04) : 478 - 486
  • [8] EVELUT®: A Real-World, Observational Study Assessing Dyspnoea and Symptom Burden in COPD Patients Switched from LABA/ICS to LAMA/LABA or LAMA/LABA/ICS
    Buhl, Roland
    Dreher, Michael
    Mattiucci-Guehlke, Muriel
    Emerson-Stadler, Rachel
    Eckhardt, Sebastian
    Taube, Christian
    Vogelmeier, Claus F.
    ADVANCES IN THERAPY, 2023, 40 (07) : 3263 - 3278
  • [9] EVELUT®: A Real-World, Observational Study Assessing Dyspnoea and Symptom Burden in COPD Patients Switched from LABA/ICS to LAMA/LABA or LAMA/LABA/ICS
    Roland Buhl
    Michael Dreher
    Muriel Mattiucci-Guehlke
    Rachel Emerson-Stadler
    Sebastian Eckhardt
    Christian Taube
    Claus F. Vogelmeier
    Advances in Therapy, 2023, 40 : 3263 - 3278
  • [10] A real-world prospective observational study of eptinezumab in Asian patients with migraine
    Zhao, Yi Jing
    Ong, Jonathan Jia Yuan
    Sonu, Sumit Kumar
    Dang, Jiaojiao
    Ng, Chai Ching
    Herr, Keira Joann
    Bose, Rohini
    Jion, Yasmin Idu
    HEADACHE, 2024, 64 (07): : 810 - 824